Pro Share Advisors LLC Amgen Inc Transaction History

Pro Share Advisors LLC

$36.5 Billion
Q2 2024

A detailed history of Pro Share Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 661,578 shares of AMGN stock, worth $213 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

661,578

Previous 711,683 7.04%

Holding current value

$213 Million

Previous $202 Million 2.16%

% of portfolio

0.57%

Previous 0.55%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $13.2 Million - $16 Million	-50,105 Reduced 7.04%	661,578 $207 Million
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $18.7 Million - $22.6 Million	69,693 Added 10.86%	711,683 $202 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $23.3 Million - $26.3 Million	-91,019 Reduced 12.42%	641,990 $185 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $12.4 Million - $15.4 Million	56,700 Added 8.38%	733,009 $197 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $8.56 Million - $10.1 Million	-39,972 Reduced 5.58%	676,309 $150 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $10.5 Million - $12.8 Million	46,476 Added 6.94%	716,281 $173 Million
Q4 2022 Feb 02, 2023	SELL	$229.03 - $291.01 $8.3 Million - $10.5 Million	-36,241 Reduced 5.13%	669,805 $176 Million
Q3 2022 Nov 04, 2022	SELL	$224.46 - $253.15 $24.9 Million - $28.1 Million	-110,872 Reduced 13.57%	706,046 $159 Million
Q2 2022 Aug 01, 2022	SELL	$230.71 - $256.74 $103 Million - $114 Million	-444,404 Reduced 35.23%	816,918 $199 Million
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $21.4 Million - $23.7 Million	-97,567 Reduced 7.18%	1,261,322 $305 Million
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $77.4 Million - $88.6 Million	389,327 Added 40.15%	1,358,889 $306 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $12.9 Million - $15.1 Million	60,805 Added 6.69%	969,562 $206 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $2.84 Million - $3.15 Million	-12,138 Reduced 1.32%	908,757 $222 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $31.3 Million - $36.5 Million	141,186 Added 18.11%	920,895 $229 Million
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $17.9 Million - $21.3 Million	82,516 Added 11.84%	779,709 $179 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $55.1 Million - $61.3 Million	234,897 Added 50.81%	697,193 $177 Million
Q2 2020 Aug 03, 2020	BUY	$197.81 - $242.74 $12.9 Million - $15.8 Million	65,217 Added 16.42%	462,296 $109 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $30 Million - $39.8 Million	-164,507 Reduced 29.29%	397,079 $80.5 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $9.43 Million - $12.1 Million	49,828 Added 9.74%	561,586 $135 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $2.85 Million - $3.41 Million	-16,346 Reduced 3.1%	511,758 $99 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $11.5 Million - $13.5 Million	-69,242 Reduced 11.59%	528,104 $97.3 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $1.81 Million - $2.04 Million	9,999 Added 1.7%	597,346 $113 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $12.6 Million - $14.7 Million	70,353 Added 13.61%	587,347 $114 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $10.4 Million - $11.7 Million	-56,078 Reduced 9.79%	516,994 $107 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $14.4 Million - $16.1 Million	-86,424 Reduced 13.1%	573,072 $106 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $5.71 Million - $6.67 Million	33,691 Added 5.38%	659,496 $112 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $20.5 Million - $23 Million	121,716 Added 24.15%	625,805 $109 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $7.66 Million - $8.74 Million	45,762 Added 9.98%	504,089 $94 Million
Q2 2017 Aug 11, 2017	BUY	N/A	458,327	458,327 $78.9 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Amgen Inc Transaction History